Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III, Prospective, Randomized, Double-blind Clinical Trial to Evaluate the Efficacy of Melatonin in Patients With Severe Sepsis or Septic Shock

NCT01858909 is registered in ClinicalTrials.gov with Aragon Institute of Health Sciences as lead sponsor.

NCT NCT01858909
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01858909 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III, Prospective, Randomized, Double-blind Clinical Trial to Evaluate the Efficacy of Melatonin in Patients With Severe Sepsis or Septic Shock
Lead sponsor
Aragon Institute of Health Sciences
Phase
Phase 3
Overall status
Unknown status
Start date
May 31, 2013
Completion date
December 31, 2013
Enrollment
110 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

septic shock, severe sepsis